Communiqués Amgen Inc.

Actions

AMGN

US0311621009

Marché Fermé - Nasdaq Autres places de cotation 22:00:01 31/05/2024			Varia. 5j.	Varia. 1 janv.
305,8 ^USD	+1,59 %		-0,01 %	+6,17 %

28/05	La FDA américaine approuve le biosimilaire d'Amgen au traitement d'AstraZeneca contre les maladies sanguines rares	RE
28/05	Les prévisions concernant les médicaments amaigrissants passent à 150 milliards de dollars en raison de l'augmentation de l'offre	RE

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Amgen : 2024 Annual Meeting of Stockholders Presentation	31/05	PU
Supreme Court Holds Invalid Cholesterol Drug Patent That Covered Millions Of Undisclosed Antibodies	27/05	AQ
Amgen : An Underrecognized Risk Factor for Heart Disease	23/05	PU
Improving treatment responses to solid tumours with trispecific TCEs	23/05	AQ
Amgen : From the Office to the Lab, Amgen Uses AI Tools to Unlock Innovation	22/05	PU
Amgen : Actress and Producer Gina Torres Urges Hispanic Americans to Prioritize Cholesterol Care	21/05	PU
Amgen : At Milken Global Conference, Bradway Calls for Protecting U.S. Policy Ecosystem That Fosters Innovation	20/05	PU
Driving Long-Term Growth: IMDELLTRA™ Approval and Information Update Presentation	20/05	PU
Astrazeneca - New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary disease	20/05	AQ
AMGEN - NEW DATA PRESENTED AT ATS 2024 SHOW THE POTENTIAL OF TEZSPIRE TO HELP PATIENTS LIVING WITH COPD	20/05	AQ
Amgen And Sandoz Settle Denosumab BPCIA Litigation	20/05	AQ
Amgen : Expanding Innovation in BiTE® Technology for Patients with Extensive Stage Small Cell Lung Cancer (ES SCLC)	17/05	PU
Court Cancels Injunction Hearings In Aflibercept BPCIA Litigation; Regeneron May Seek Temporary Restraining Orders	16/05	AQ
Amgen : Trusting Your Gut	15/05	PU
Understanding Product-By-Process Claims In Patent Law	14/05	AQ
Enabling The "Full Scope" Of Claims In View Of The Supreme Court's Decision In Amgen	13/05	AQ
AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE	09/05	PR
CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904	09/05	AQ
Amgen : A Journey to Inclusion During Asian American Pacific Islander Month	08/05	PU
Five Key Takeaways From FDA's Updated Draft Guidance On Biosimilars Promotion	08/05	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Amgen Inc.

Actions

AMGN

US0311621009

Communiqués

Filtres